Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Inflamm Bowel Dis

Search In Journal Title:

Abbravation: Inflammatory Bowel Diseases

Search In Journal Abbravation:

Publisher

Narnia

Search In Publisher:

DOI

10.1002/jps.2600681206

Search In DOI:

ISSN

1078-0998

Search In ISSN:
Search In Title Of Papers:

Multidrug resistance gene1 polymorphisms and resi

Authors: Daniel Fady Loriot MarieAnne Seksik Philippe Cosnes Jacques Gornet JeanMarc Lémann Marc Fein Francine VernierMassouille Gwenola De Vos Martine Boureille Arnaud Treton Xavier Flourié Bernard Roblin Xavier Louis Edouard Zerbib Frank Beaune Philippe Marteau Philippe
Publish Date: 2007/01/01
Volume: 13, Issue: 1, Pages: 19-23
PDF Link

Abstract

Fady Daniel MarieAnne Loriot Philippe Seksik Jacques Cosnes JeanMarc Gornet Marc Lémann Francine Fein Gwenola VernierMassouille Martine De Vos Arnaud Boureille Xavier Treton Bernard Flourié Xavier Roblin Edouard Louis Frank Zerbib Philippe Beaune Philippe Marteau Multidrug resistance gene1 polymorphisms and resistance to cyclosporine a in patients with steroid resistant ulcerative colitis Inflammatory Bowel Diseases Volume 13 Issue 1 1 January 2007 Pages 19–23 https//doiorg/101002/ibd20046Cyclosporine A CsA is inconstantly effective in inducing remission in acute attacks of ulcerative colitis UC not responding to steroids This study aimed to establish whether multidrug resistance gene MDR1 polymorphisms would be associated with CsA failureThe distribution of the different genotypes of single nucleotide polymorphisms SNP G2677T/A and C3435T of MDR1 exons 21 and 26 respectively was studied in 154 patients mean age 44 yr who had received CsA to treat severe attacks of steroid resistant UC in 11 centers in France and Belgium Patients were classified as CsA failure n = 50 when they needed colectomy within 30 days after CsA initiation The SNPs were detected by use of a 5′ nuclease allelic discrimination assayThere was a significant association between the G2677T/A polymorphism distribution exon 21 and the risk for CsA failure P = 00001 The TT genotype of exon 21 was significantly associated with the risk compared with the two other genotypes odds ratio 377 95 confidence interval 142–997 P = 0007 There was no significant association between the genotype C3435T distribution exon 26 and the risk of CsA failure P = 023The TT genotype of exon 21 MDR1 polymorphisms is associated with a higher risk of CsA failure in patients with steroid resistant UC Further studies should be performed to establish whether other treatments could be more efficient to avoid surgery in this subset of patients


Keywords:

References

citation journal title=Gastroenterology citation year=2005 citation volume=28


.
Search In Abstract Of Papers:
Other Papers In This Journal:

  1. Gender and Location of CRC in IBDImplications for Surveillance Protocols
  2. Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent
  3. Targeting TNF in Postoperative Recurrence of Crohn's Disease:Can We Extinguish the Fire Before It Starts?
  4. Gene Expression Profiling Identifies Mechanisms of Protection to Recurrent Trinitrobenzene Sulfonic Acid Colitis Mediated by Probiotics
  5. Adalimumab Therapy in Crohn's Disease of the Ileal Pouch
  6. Observations on Severity and Activity Indices in a Therapeutic Trial of Active Crohn's Disease
  7. Splenic function and IgM-memory B cells in Crohn's disease patients treated with infliximab
  8. One-year Investigator-blind Randomized Multicenter Trial Comparing Asacol 2.4 g Once Daily with 800 mg Three Times Daily for Maintenance of Remission in Ulcerative Colitis
  9. Role of diet in the development of inflammatory bowel disease
  10. Thromboembolism in pediatric inflammatory bowel disease: Systematic review
  11. Potential Oncogenic Properties of Mobilized Stem Cells in a Subpopulation of Inflammatory Bowel Disease Patients Infected with Helicobacter pylori
  12. Potential Oncogenic Properties of Mobilized Stem Cells in a Subpopulation of Inflammatory Bowel Disease Patients Infected with Helicobacter pylori
  13. Twin Studies Reveal Specific Imbalances in the Mucosaassociated Microbiota of Patients with Ileal Crohn's Disease
  14. Microbial Causation of the Chronic Idiopathic Inflammatory Bowel Diseases
  15. Babesiosis in a Patient on Infliximab for Crohn's Disease
  16. Plasma Chromogranin A in Patients With Inflammatory Bowel Disease: A Possible Explanation
  17. Effect of Adalimumab on Clinical Laboratory Parameters in Patients with Crohn's Disease: Results from the CHARM Trial
  18. Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease
  19. What is the incidence, prevalence, and natural history of indeterminate colitis?
  20. Anti-tumor Necrosis Factor and Postoperative Complications in Crohn's Disease: Systematic Review and Meta-analysis
  21. Effects of T cell-induced colonic inflammation on epithelial barrier function†
  22. Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients
  23. Dangers associated with endoscopic management of strictures in IBD
  24. Combination of innate and adaptive immune alterations increased the likelihood of fibrostenosis in Crohn's disease†
  25. Role of the interleukin 24 in patients with ulcerative colitis
  26. Antibodies Against Cyclic Citrullinated Peptide (CCP) in Inflammatory Bowel Disease Patients With or Without Arthritic Manifestations
  27. Nitric Oxide and Colitis: Rats, Humans and Now Macaques
  28. Distinct Microbiome in Pouchitis Compared to Healthy Pouches in Ulcerative Colitis and Familial Adenomatous Polyposis
  29. Is Crohn's creeping fat an adipose tissue?
  30. Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease
  31. Cyclosporine in the management of severe ulcerative colitis while breast-feeding
  32. Nailing down the shingles in IBD
  33. Local Injection of Infliximab in Symptomatic Isolated Mucosal LesionsA Novel Scenario for Endoscopic Therapy?
  34. A New Type of Strictureplasty for the Treatment of Multiple Long Stenosis in Crohn's Disease

Search Result: